Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have molecular adaptor activity and protein domain specific binding activity. Predicted to be involved in regulation of postsynaptic neurotransmitter receptor activity. Localizes to several cellular components, including cholinergic synapse; glutamatergic synapse; and neuromuscular junction. Is expressed in nervous system and neural retina. Used to study autism spectrum disorder. Orthologous to human DLGAP4 (DLG associated protein 4).